Zyme Communications

@sptlabtech.bsky.social and @alitheagenomics.bsky.social have collaborated to provide an automated solution for single-cell transcriptomics, integrating the MERCURIUS FLASH-seq with SPT’s firefly platform for high-throughput, cost efficient single-cell sequencing: www.sptlabtech.com/news/spt-lab...

Today Optibrium introduced the latest release of its comprehensive molecular design platform, StarDrop 8, integrating collaboration at every stage of the discovery process enabling medicinal chemists to progress more quickly from hit to candidate.

Read more here: bit.ly/4nGfpn9

Today Nuclera announced expanded access to its eProtein Discovery System for APAC customers through a distributor agreement with Solve Scientific in Australia and New Zealand, providing localised support and expertise to scientists in these regions.

bit.ly/3LsJYz3

@proimmune.bsky.social has introduced ProVE SL Self-Loading Class I Monomers, designed to offer unprecedented flexibility, speed and MHC allele-coverage in T cell research, with over 50 alleles available.

Read more: www.proimmune.com/news

VALANX Biotech has appointed Klaus Orlinger, PhD. as CSO.

Klaus is an experienced R&D leader with a distinguished track record in pharmaceutical product development joining VALANX from HOOKIPA Pharma, where he served as CSO, VP Research, and Head of Virology.

Read more here: rb.gy/qva8kz

Today Qureight announced that its Vascul8™ model for pulmonary vascular disorders has been validated in a peer reviewed study, offering the potential to improve treatment options and patient outcomes following surgery.

Read the full press release here: bit.ly/48OeEo5

OMED Health, part of @owlstonemedical.bsky.social, has partnered with Aviva to deliver a pilot study, providing 75 Aviva employees with OMED Health Plans.

The collaboration will evaluate the impact of the OMED solution on the digestive health of participants: www.owlstonemedical.com/about/news/2...

Biodesix has expanded its partnership agreement with @biorad24.bsky.social to develop in vitro diagnostic assays for highly sensitive detection of genomic markers focused on oncology applications, utilizing Bio-Rad’s ddPCR™ technology & QX600 platform.

More here: rb.gy/5wbz3q

@proimmune.bsky.social has expanded into new global headquarters at Oasis Park, Oxford, supporting the continued development of ProImmune’s REVEAL Immunogenicity System and Ankyron target binding technologies.

Read more: proimmune.com/news

giles AI has introduced giles, its specialised research agent designed to support healthcare, clinical, and medical research by optimising research intelligence for scientific text comprehension, enabling extraction and summarisation of academic papers: giles.app/press-releas...

Bio-Rad Laboratories today announced that MicroVal, the international certification organization, has approved the iQ-Check Enterobacteriaceae Kit for real time detection of Enterobacteriaceae in infant formula, infant cereal, and related ingredients: www.bio-rad.com/en-uk/life-s...

Today Enamine announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of ASAP-0017445, a promising broad-spectrum coronavirus antiviral pre-clinical candidate.

Read more: enamine.net/news-press-r...

.@MosaicTXLtd has appointed Thomas Fuchs as CEO.

With over 25 years of experience across drug development and commercialisation, Thomas will lead the Company to advance its pipeline of proprietary drug combination programmes into the clinic: mosaic-tx.com/wp-content/u...

Cyclana Bio today announced the close of a £5M pre-seed funding round that will enable the Company to develop functional disease models and its platform, for the identification of druggable targets in endometriosis.

More here: www.cyclanabio.com/general-8

@sptlabtech.bsky.social and @10xgenomics.bsky.social have partnered to provide automated workflows for single cell research, scaling experiments on 10x’s Chromium Single Cell platform using plug-and-play protocols on SPT Labtech’s firefly platform: www.sptlabtech.com/news/spt-lab...

This morning, CN Bio announced the launch of its all-in-one Organ-on-a-chip system, PhysioMimix Core.

The system combines the capabilities of CN Bio’s existing suite of instruments, enabling single-, multi-organ and higher-throughput configurations within one scalable platform.

bit.ly/3W6HxEv

@sptlabtech.bsky.social and Agilent Technologies have introduced automated targeted enrichment protocols for genomic workflows. The protocols on SPT Labtech’s firefly+ platform use Agilent’s SureSelect Max DNA Library Prep Kits to increase reproducibility and reduce costs: tinyurl.com/5fmtwuf5

FairJourney Biologics today announced the appointment of Dr. Werner Lanthaler as CEO, who previously served as Evotec SE CEO for 15 years.

Founder António Parada will focus on driving the Company's innovation strategy on the Supervisory Board.

Read more here: rb.gy/c31dis

Owlstone Medical has won an award of up to $49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) for the POSEIDON program, which aims to develop synthetic-sensor based Multi Cancer-Early Detection (MCED) at-home breath and urine tests: www.owlstonemedical.com/about/news/2...

@bio-rad.bsky.social has announced a strategic agreement with Gencurix that will establish Bio-Rad as the exclusive distributor of Gencurix’ CE-IVD Droplex™ digital PCR oncology testing kits throughout Europe.

More here: rb.gy/67rc7e

Tagomics published a peer-reviewed study in Cell Reports Methods, underpinning its epigenomic profiling technology, Active-Seq, the basis of Tagomics’ ActivaceTM platform
➡️ bit.ly/4nmE2FU

Miebach Consulting has expanded its facilities at Abingdon Science Park, doubling its footprint with a new bespoke space in The Science Quadrant.

Delivered by Kadans Science Partner, the new facilities offer flexible workspaces to support future growth: www.kadans.com/news/miebach...

Today SynGenSys announced the launch of NK.SET™, the first commercially available NK (natural killer) cell-specific promoter library enabling precise and controllable gene expression.

Read the full press release here: www.syngensys.com/resources/nk

Today Atelerix announced it has entered into a new distribution agreement with CliniSciences, a leading European player in the distribution and development of solutions for research and diagnostics, improving access to its non-cryogenic cell preservation solutions.

Read more: shorturl.at/uFlyo

Today @trimtechtx.bsky.social announced it has been named as one of Fierce Biotech’s ‘Fierce 15’ for 2025.

The company is creating novel, aggregate-selective, targeted protein degraders to combat neurodegenerative and inflammatory diseases such as Alzheimer’s.

Read more: shorturl.at/IRTJO

Today Closed Loop Medicine announced the U.S. launch of WeDosify, the Company’s first commercially available product, which enables clinicians to personalize GLP-1 titration at scale.

Read more: www.closedloopmedicine.com/closed-loop-...

Today @enhancedgenomics.bsky.social announced it has completed a financing round, extending its total Series A funding to $19 million. The funding will be used to drive therapeutics discovery in common diseases with high unmet medical need.

Read more: shorturl.at/xQdeb

Today FUJIFILM Biosciences introduced BalanCD HEK293 Perfusion A Medium, the first commercially available cell culture solution that uses a suspension of HEK293 cell and perfusion technology to streamline production of viral vectors for gene therapies.

bit.ly/465mAj1

@eppendorf.bsky.social has introduced next generation mechanical pipettes.

The Eppendorf Research 3 neo pipette is designed to deliver accurate and precise results for accelerated volume selection and optimised ergonomics and is now available in Asia, EMEA and the Americas.

bit.ly/46lc0ED

Today, Atelerix has announced a new agreement with Rodon Global to broaden access to safe shipping and storage solutions for temperature-sensitive biomaterials, without freezing.

Read the full release: bit.ly/3JGIK2t